Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX vs Capecitabine Maintenance in Elderly Gastric Cancer
NCT01798251Phase 2Unknown
- Sponsor
- Harbin Medical University
- Start
- Dec 2012
- Primary completion
- Dec 2014
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in gastric adenocarcinoma, sponsored by Harbin Medical University. Status: unknown.
02
Drugs
capecitabine
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT01798251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798251.